Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03823534Phase 3Recruiting
Phase 3, randomised trial of ketorolac in pain (2 arms), sponsored by Saint Louis University. Primary endpoint: Milligram Morphine Equivalent of Opioid Medications Utilized. Started Feb 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03823534.